Головна / Новини / WHO Medical Product Alert N°7/2020 on HARVONI (Ledipasvir/sofosbuvir) identified in the WHO regions of the Americas and Europe in Brazil and Turkey

WHO Medical Product Alert N°7/2020 on HARVONI (Ledipasvir/sofosbuvir) identified in the WHO regions of the Americas and Europe in Brazil and Turkey

Опубліковано 28.01.2021 о 18:17

The State Service of Ukraine on Medicines and Drugs Control received information regarding one batch of confirmed falsified HARVONI (Ledipasvir/sofosbuvir) identified in Brazil and Turkey. The product name is HARVONI 90 mg/400 mg. with batch number 22VMYVA12 and German packaging language. The stated manufacturer is Gilead Sciences.

More detailed information is available on the WHO website:

https://www.who.int/news/item/08-12-2020-medical-product-alert-n-7-2020

 

 *Pay attention! The medicine HARVONI registered in Ukraine has packaging language in Ukrainian and Russian.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

WHO Medical Product Alert N°6/2020 on falsified Fluzone® Quadrivalent Influenza Vaccine identified in WHO region of the Americas in Mexico

Наступна

Memorandum on cooperation with the Public Health Center has been signed